$1M funding for AI drug discovery for rare diseases and more digital health fundings

Peptris Technologies, an Indian AI drug discovery firm, received $1 million to expand research to rare diseases. Cipla, a pharmaceutical company, increased its stake in GoApptiv to improve access to medications in underserved communities. Lydia AI, a Canadian insurtech, has partnered with South Korean companies to integrate its AI technology into health insurance applications. Ubie, a Japanese startup, is launching an Android version of its AI symptom checker app in the US, with over 100 million uses since 2020.

Source link